Image

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Join a study testing new diabetes, blood pressure, and heart treatments.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for people with type 2 diabetes, high blood pressure, and heart disease. The study tests if a medicine called vicadrostat, when taken with another medicine, empagliflozin, can lower heart risks. People in the study are split into two groups by chance. One group will take vicadrostat and empagliflozin, while the other takes a placebo (a harmless pill that looks like the real one) with empagliflozin. The study lasts up to 4 years and 3 months. Participants take one tablet daily, continue their regular medicines, and visit the study site for health checks and blood tests. Doctors track any heart-related events or side effects.

  • **Length**: Up to 4 years and 3 months with regular visits.
  • **Participation**: Randomly assigned to medicine or placebo.
  • **Monitoring**: Regular health and blood tests, tracking side effects.

This study is not for people with a history of heart failure. Participants must be 18 or older and women must use effective birth control. Certain medications and heart conditions may exclude someone from participating.

Print
Study details
    Diabetes Mellitus
    Type 2
    Hypertension
    Cardiovascular Diseases

NCT07064473

Boehringer Ingelheim

11 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.